[
  {
    "ts": null,
    "headline": "AMD & Pfizer earnings, ISM services data: What to Watch",
    "summary": "Market Domination Overtime host Josh Lipton takes a look at the top stories for investors to watch on Tuesday, Aug. 5. In the morning, Caterpillar (CAT) and Pfizer (PFE) will announce earnings results. Advanced Micro Devices (AMD), Amgen (AMGN), Snap (SNAP), and Rivian (RIVN) will announce results in the afternoon. In the morning, Institute for Supply Management (ISM) services data for July will be released. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.",
    "url": "https://finnhub.io/api/news?id=5a59ed8c6f508eb060cb2792abddcbf0e98a05faba69aeee0b9a8a5de103d33f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754348400,
      "headline": "AMD & Pfizer earnings, ISM services data: What to Watch",
      "id": 136205791,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Market Domination Overtime host Josh Lipton takes a look at the top stories for investors to watch on Tuesday, Aug. 5. In the morning, Caterpillar (CAT) and Pfizer (PFE) will announce earnings results. Advanced Micro Devices (AMD), Amgen (AMGN), Snap (SNAP), and Rivian (RIVN) will announce results in the afternoon. In the morning, Institute for Supply Management (ISM) services data for July will be released. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.",
      "url": "https://finnhub.io/api/news?id=5a59ed8c6f508eb060cb2792abddcbf0e98a05faba69aeee0b9a8a5de103d33f"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. stock underperforms Monday when compared to competitors despite daily gains",
    "summary": "Amgen Inc. stock underperforms Monday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=34f53f60a78fa711a59ce628b3dfc3a5245b40ab240f7b7efd3b36daa2e0751e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754325300,
      "headline": "Amgen Inc. stock underperforms Monday when compared to competitors despite daily gains",
      "id": 136210326,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock underperforms Monday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=34f53f60a78fa711a59ce628b3dfc3a5245b40ab240f7b7efd3b36daa2e0751e"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk Before Q2 Earnings: How Should Investors Play the Stock?",
    "summary": "NVO's second-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, Wegovy, Ozempic and Rybelsus.",
    "url": "https://finnhub.io/api/news?id=0eac8f187113e1b78efd6b7fc662d8d0b1ac7154585942624f8832fb1cd705c6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754322540,
      "headline": "Novo Nordisk Before Q2 Earnings: How Should Investors Play the Stock?",
      "id": 136200227,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "NVO's second-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, Wegovy, Ozempic and Rybelsus.",
      "url": "https://finnhub.io/api/news?id=0eac8f187113e1b78efd6b7fc662d8d0b1ac7154585942624f8832fb1cd705c6"
    }
  },
  {
    "ts": null,
    "headline": "Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?",
    "summary": "Let's look at five pharma and biotech companies, PFE, LLY, AMGN, GILD and NVO, which are scheduled to release their second-quarter 2025 results this week.",
    "url": "https://finnhub.io/api/news?id=883190f0e2f70a7ee2c2c89d4029b1a0d3a68266fb7467a0b0963edd4dee601a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754322480,
      "headline": "Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?",
      "id": 136200228,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Let's look at five pharma and biotech companies, PFE, LLY, AMGN, GILD and NVO, which are scheduled to release their second-quarter 2025 results this week.",
      "url": "https://finnhub.io/api/news?id=883190f0e2f70a7ee2c2c89d4029b1a0d3a68266fb7467a0b0963edd4dee601a"
    }
  },
  {
    "ts": null,
    "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
    "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
    "url": "https://finnhub.io/api/news?id=5737c823eaccf70175ba83bf7eb3c16dafd5b3b93b724474a215c479dcd0e267",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754312403,
      "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
      "id": 136200381,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
      "url": "https://finnhub.io/api/news?id=5737c823eaccf70175ba83bf7eb3c16dafd5b3b93b724474a215c479dcd0e267"
    }
  },
  {
    "ts": null,
    "headline": "Central Bank Outlook Lifts Wall Street Pre-Bell; Asia, Europe Up",
    "summary": "Wall Street futures pointed moderately higher pre-bell Monday as traders weighed odds that the Feder",
    "url": "https://finnhub.io/api/news?id=00f5597fd509970a0aa122ae34451d3f2c148ce5ac685713d4231e5e774389a4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754305852,
      "headline": "Central Bank Outlook Lifts Wall Street Pre-Bell; Asia, Europe Up",
      "id": 136197847,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Wall Street futures pointed moderately higher pre-bell Monday as traders weighed odds that the Feder",
      "url": "https://finnhub.io/api/news?id=00f5597fd509970a0aa122ae34451d3f2c148ce5ac685713d4231e5e774389a4"
    }
  },
  {
    "ts": null,
    "headline": "Lilly’s Push to $1 Trillion Derailed by Trade Risks and Obesity Drug Speedbumps",
    "summary": "(Bloomberg) -- A year ago, Eli Lilly & Co. was poised to become the first pharmaceutical company to register a trillion-dollar market valuation. It still hasn’t cracked that ceiling.Most Read from BloombergSeeking Relief From Heat and Smog, Cities Follow the WindChicago Curbs Hiring, Travel to Tackle $1 Billion Budget HoleNYC Mayor Adams Gives Bally’s Bronx Casino Plan a Second ChanceInstead, a series of weak earnings reports, a setback for its obesity drug and threats of sky-high tariffs have t",
    "url": "https://finnhub.io/api/news?id=898c354f6d01951df2f7b782b1f22cde1986fb5dca64e9e678dd3044db2963e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754305201,
      "headline": "Lilly’s Push to $1 Trillion Derailed by Trade Risks and Obesity Drug Speedbumps",
      "id": 136197848,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- A year ago, Eli Lilly & Co. was poised to become the first pharmaceutical company to register a trillion-dollar market valuation. It still hasn’t cracked that ceiling.Most Read from BloombergSeeking Relief From Heat and Smog, Cities Follow the WindChicago Curbs Hiring, Travel to Tackle $1 Billion Budget HoleNYC Mayor Adams Gives Bally’s Bronx Casino Plan a Second ChanceInstead, a series of weak earnings reports, a setback for its obesity drug and threats of sky-high tariffs have t",
      "url": "https://finnhub.io/api/news?id=898c354f6d01951df2f7b782b1f22cde1986fb5dca64e9e678dd3044db2963e7"
    }
  },
  {
    "ts": null,
    "headline": "Do Wall Street Analysts Like Amgen Stock?",
    "summary": "Amgen has notably outpaced the broader market and the healthcare sector in 2025, and analysts remain cautiously optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=2039d083ed3f7867248531f1329a097bd4298334580fceeb82314098d66fd9d8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754291945,
      "headline": "Do Wall Street Analysts Like Amgen Stock?",
      "id": 136198051,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen has notably outpaced the broader market and the healthcare sector in 2025, and analysts remain cautiously optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=2039d083ed3f7867248531f1329a097bd4298334580fceeb82314098d66fd9d8"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Global Life Sciences Fund Q2 2025 Commentary",
    "summary": "Janus Henderson reviews Q2 healthcare headwinds and standout biotech picks. Learn how the fund is navigating policy shifts and finding innovation upside.",
    "url": "https://finnhub.io/api/news?id=0b87039d99d7e9cf0a9a88ab06e6861b276113fa4e554693cfbacf40d7eb67b3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754288400,
      "headline": "Janus Henderson Global Life Sciences Fund Q2 2025 Commentary",
      "id": 136196996,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/172204552/image_172204552.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Janus Henderson reviews Q2 healthcare headwinds and standout biotech picks. Learn how the fund is navigating policy shifts and finding innovation upside.",
      "url": "https://finnhub.io/api/news?id=0b87039d99d7e9cf0a9a88ab06e6861b276113fa4e554693cfbacf40d7eb67b3"
    }
  },
  {
    "ts": null,
    "headline": "Earnings To Watch: Amgen (AMGN) Reports Q2 Results Tomorrow",
    "summary": "Biotech company Amgen (NASDAQ:AMGN) will be reporting results this Tuesday after market hours. Here’s what to look for.",
    "url": "https://finnhub.io/api/news?id=84fb596e95611597320a9453ee33b6f6a6eae7448126cef364a955b3e6fb1bf9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754277257,
      "headline": "Earnings To Watch: Amgen (AMGN) Reports Q2 Results Tomorrow",
      "id": 136195534,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Biotech company Amgen (NASDAQ:AMGN) will be reporting results this Tuesday after market hours. Here’s what to look for.",
      "url": "https://finnhub.io/api/news?id=84fb596e95611597320a9453ee33b6f6a6eae7448126cef364a955b3e6fb1bf9"
    }
  }
]